Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

Dr. Eva Colás' research has been one of the ten Biology and Biomedicine studies awarded with a Leonardo grant this 2022.

The Interuniversity Research led by the NeuroPhar laboratory of the UPF has discovered that modulating the endocannabinoid system considerably improves some of the effects of the pathology.

Lesions present low levels of miR-885-5p, and this increases keratinocyte proliferation, the attraction of inflammatory cells and also the production of inflammatory mediators.

Understanding the changes that the fetus undergoes when exposed to cannabis will help to improve the prevention of consumption and the monitoring of pregnant cannabis users.

The presentations address the discovery of new drugs and therapeutic targets, clinical trial results and the improvement of clinical practice and patient experience.

The technique developed at Vall d'Hebron Research Institute (VHIR) uses a "switch" to block the reproduction of neuroblastoma cells

The international study has identified 89 genes involved in the risk of developing a stroke, 61 of which had not been previously described.

This is the first international study on the incidence of Mediterranean nutrition on the side effects of cancer treatments and survival of pediatric cancer patients.

El projecte pretén oferir un tractament precoç i localitzat en el moment de la teràpia de reperfusió per reduir significativament el dany del teixit i minimitzar l'aparició de complicacions cardíaques en el futur.

La Societat Europea de Coloproctologia és una de les dues societats més rellevants a nivell internacional del seu sector.

The VHIR and CEMCAT nurse has been recognized for his leadership of the Catalonia Expert Patient program in this disease.

On World Cancer Research Day, we highlight the impact of VHIR projects in the field of oncology.

The study, coordinated by Vall d'Hebron, aims to facilitate access to personalized medicine for all children and adolescents with cancer, regardless of where they live.

It is the project “New Nanotechnological Therapy for Parkinson’s disease: Nose to Brain Delivery of GBA-Polymer Nanoconjugates (nanoGBAtoBrain)”.

En les consultes de la Unitat de Tractament Integral de l’Obesitat de Vall d’Hebron els avenços de la recerca estan molt presents, ja sigui en forma d’assaig clínic o mitjançant la utilització d’unes ulleres de realitat virtual.

Entre els projectes es troben 12 investigacions on participen investigadors i investigadores de Vall d’Hebron.

Onze investigadors i investigadores de Vall d’Hebron faran xerrades i tallers amb l’objectiu d’apropar la ciència a tothom.

The paper has shown that those patients who are not able to normalize their microbiome after surgery have a worse prognosis.

Researchers have presented advances in the field of myocardial infarction, non-compaction cardiomyopathy and genetic aortic pathology, in addition to hosting a meeting between international experts on vascular aging.

The different members of the network met in Vall d’Hebron to share their innovations processes, needs, challenges, and goals

The international study incorporates new magnetic resonance markers to increase sensitivity in the diagnosis of this disease.

The paper that analyzed to what degree the most commonly prescribed immunosuppressants increase the likelihood of melanoma was considered the best communication at the national congress of dermatology

A l'estudi hi participaran 200 persones voluntàries i es durà a terme a 10 hospitals espanyols, entre els quals Vall d’Hebron.

The research team on liver transplantation in children led by Dr. Jesús Quintero has received two awards for the best oral communications and a grant.